Skip to content
Editas Medicine logo

Editas Medicine

Overview

At Editas Medicine, our mission and commitment is to harness the power and potential of CRISPR gene editing to develop a robust pipeline of medicines for people living with serious diseases around the world. Our goal is to discover, develop, manufacture, and commercialize transformative, durable genomic medicines for many diseases. CRISPR (pronounced “crisper”) is an acronym for “Clustered, Regularly Interspaced, Short Palindromic Repeats,” and refers to a recently developed gene editing technology that can revise, remove, and replace DNA in a highly targeted manner. At Editas Medicine, we are using this technology to develop transformative and durable medicines for people living with serious diseases.

Live roles (0)

No live roles are listed for Editas Medicine right now. Check their careers page for current roles (opens in a new tab).